| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |